Cart
sales@molnova.com
SU 5214
CAS No. 186611-04-1
SU 5214( SU 5214 )
Catalog No. M18154 CAS No. 186611-04-1
SU 5214 is a modulator of tyrosine kinase signal transduction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 116 | In Stock |
|
| 100MG | 191 | In Stock |
|
| 200MG | 277 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU 5214
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU 5214 is a modulator of tyrosine kinase signal transduction.
-
DescriptionSU 5214 is a modulator of tyrosine kinase signal transduction.
-
In Vitro——
-
In Vivo——
-
SynonymsSU 5214
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number186611-04-1
-
Formula Weight251.29
-
Molecular FormulaC16H13NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (397.96 mM)
-
SMILESCOc1ccccc1/C=C/1\c2ccccc2NC1=O
-
Chemical Name3-(2-Methoxy-benzylidene)-1,3-dihydro-indol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Silva JC,et al.Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions. Sci Rep. 2016 Oct 18;6:35284.
molnova catalog
related products
-
(S)-OSMI 3
(S)-OSMI 3 (Ent-OSMI-3) has anti-inflammatory and anti-tumour activity and can be used to study diabetes and neurodegenerative diseases.
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
Vonlerolizumab
Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.
